Horn & Co
We only have limited information for this firm. Consider the following firms which have provided more information:
With a significant focus on the healthcare sector, Horn & Co is noted for handling a range of cross-border transactions and corporate restructuring operations. Practice head Yuval Horn is the key contact, routinely representing clients from the hi-tech and life sciences industries on international transactions. Keren Kanir specialises in corporate finance and commercial transactions surrounding intellectual property matters.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Very professional, dedicated, and effective.’
Abbreviated data is displayed for this firm.
Key clients
- Biosight Ltd.
- Panaxia Pharmaceutical Industries Ltd.
Abbreviated data is displayed for this firm.
Work highlights
- Advised Vascular Biogenics Ltd., an Israeli company traded on the Nsadaq on a merger transaction with Notable Labs, Inc., a US private company under which Notable Labs will merge into a wholly owned subsidiary of VBL, with Notable surviving as a wholly owned subsidiary of VBL.
- Advised INX Digital Company, Inc., a publicly traded company incorporated under the laws of British Columbia, which entered into a series of agreements with Republic, a Billion Dollar US company, for a multistep financial and commercial collaboration, under which Republic shall invest in INX and purchase shares which constitute 9.5% of the issued and outstanding share capital of INX.
Abbreviated data is displayed for this firm.